Shaking down new epilepsy genes

Nature Medicine

Volumn 2, Issue 5, 1996, Pages 516-518

  Allen, Kristina M ^a   Walsh, Christopher ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTATIN B; UNCLASSIFIED DRUG;

BENIGN CHILDHOOD EPILEPSY; FOCAL EPILEPSY; GENE LOCATION; HUMAN; MOLECULAR CLONING; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; SHORT SURVEY;

ANTICONVULSANTS; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; EPILEPSIES, MYOCLONIC; EPILEPSY; HUMANS;

EID: 0029927015     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0596-516     Document Type: Short Survey

References (19)

1. Pennachio, L.A. et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271, 1731-1733 (1996).
2. Turk, V. & Bode, W. The cystatins: Protein inhibitors of cysteine proteinases. FEBS Lett. 285, 213-219 (1991).
3. Steinlein O.K. et al. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genet. 11, 201-203 (1995).
4. Beck, C. et al. A nonsense mutation in the α-4 subunit of the nicotinic acetylcholine receptor (CHRNA4) cosegregates with 20q-linked benign neonatal familial convulsions (EBN1) Neurobiol. Dis. 1, 95-99 (1994).
5. Shiang, R. et al. Mutations in the α1 subunit of the inhibitory glycine receptor cause the dominant neurological disorder, hyperekplexia. Nature Genet. 5, 351-358 (1993).
6. Ryan, S.G. et al. A missense mutation in the gene encoding the α1 subunit of the inhibitory glycine receptor in the spasmodic mouse. Nature Genet. 7, 131-135 (1994).
7. Rosahl, T.W. et al. Essential functions of synapsins I and II in synaptic vesicle regulation. Nature 375, 488-493 (1995).
8. Li, L. et al. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin Ideficient mice. Proc. Natl. Acad. Sci. USA 92, 9235-9239 (1995).
9. Ferreira, A. et al. Suppression of synapsin II inhibits the formation and maintenance of synapses in hippocampal culture. Proc. Natl. Acad. Sci. USA 92, 9225-9229 (1995).
10. Pieribone, V.A. Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375, 493-497 (1995).
11. 2+ calmodulin-dependent kinase II α-subunit mutation. Proc. Natl. Acad. Sci. USA 92, 6852-6855 (1995).
12. Waymire, K.G. et al. Mice lacking tissue nonspecific alkaline phosphatase die from seizures due to defective metabolism of vitamin B-6. Nature Genet. 11, 45-51 (1995).
13. Ryan, S.G. Partial epilepsy: Chinks in the armour. Nature Genet. 10, 4-6 (1995).
14. Zara, F. et al. Mapping of genes predisposing to idiopathic generalized epilepsy. Hum. Mol. Genet. 4, 1201-1207 (1995).
15. Steinlein, O. et al. Refinement of the localization of the gene for neuronal nicotinic acetylcholine receptor α4 subunit (CHRNA4) to human chromosome 20q13.2-q13.3. Genomics 22, 493-495 (1994).
16. Tahvanainen, E. et al. The gene for a recessively inherited human childhood progressive epilepsy with mental retardation maps to the short arm of chromosome 8. Proc. Natl. Acad. Sci. USA 91, 7267-7270 (1994).
17. International Batten Disease Consortium. Isolation of a novel gene underlying Batten disease, CLN3. Cell 82, 949-957 (1995).
18. Serratosa, J.M. et al. The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. Hum. Mol. Genet. 4, 1657-1663 (1995).
19. Eksioglu, Y.Z. et al. Periventricular heterotopia: An X-linked dominant epilepsy locus causing aberrant cerebral cortical development. Neuron 16, 77-87 (1996).